GCP
APYX icon

GSA Capital Partners’s Apyx Medical APYX Stock Holding History

GSA Capital Partners’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-41,593
Closed -$209K – 1476
2023
Q2 		$209K Sell
41,593
-171,549
-80% -$869K 0.02% 1239
2023
Q1 		$614K Buy
213,142
+121,454
+132% +$355K 0.06% 584
2022
Q4 		$215K Buy
+91,688
New +$280K 0.03% 1141
2020
Q4 		– Sell
-26,772
Closed -$126K – 1186
2020
Q3 		$126K Buy
+26,772
New +$133K 0.02% 1101
2019
Q2 		– Sell
-18,800
Closed -$119K – 1422
2019
Q1 		$119K Buy
18,800
+100
+0.5% +$774 0.01% 1315
2018
Q4 		$121K Buy
18,700
+8,500
+83% +$51.5K 0.01% 1196
2018
Q3 		$72K Buy
+10,200
New +$56.7K ﹤0.01% 1578

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

GSA Capital Partners's APYX Position: Q3 2023 in Review

GSA Capital Partners sold out of Apyx Medical (APYX) in Q3 2023, closing a stake of 41,593 shares — an estimated $209K sold.

GSA Capital Partners first reported a position in APYX in Q3 2018 and held it in 7 quarters. The position peaked at $614K in Q1 2023. 62 funds tracked by Wall St. Rank hold APYX as of Q3 2023.

  • GSA Capital Partners reported no remaining Apyx Medical position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 41,593 Apyx Medical shares in Q3 2023, an estimated $209K.
  • GSA Capital Partners first reported a position in Apyx Medical in Q3 2018 and held it in 7 quarters.
  • GSA Capital Partners's Apyx Medical position peaked at $614K in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.